About Hunter Syndrome

Overview
Hunter syndrome, also known as mucopolysaccharidosis type II (MPS II), is a rare genetic disorder. It is caused by a deficiency of the enzyme Iduronate-2-Sulfatase (IDS), which leads to the progressive accumulation of substances called glycosaminoglycans (GAGs) in various organs of the body. This accumulation of GAGs can affect the functioning of organs and tissues, leading to a range of symptoms and complications. Hunter syndrome is an X-linked recessive disorder, meaning it primarily affects males. It is a chronic condition that requires ongoing management and treatment to slow down its progression and manage symptoms.
Causes and Risk Factors

Hunter syndrome, also known as mucopolysaccharidosis type II, is a rare genetic disorder caused by a deficiency of the enzyme Iduronate-2-Sulfatase (IDS). This enzyme is responsible for breaking down certain substances called glycosaminoglycans (GAGs) in the body. Without enough IDS, GAGs build up in the body's cells and tissues, leading to various symptoms and complications.

The main cause of Hunter syndrome is a genetic mutation that affects the IDS gene. This mutation is passed down from parents to their children. Hunter syndrome is an X-linked recessive disorder, which means it primarily affects males. However, in rare cases, females can also be affected if they inherit two copies of the mutated gene.

In the case of Hunter Syndrome, risk factors include:

  • Genetic predisposition: Having a family history of Hunter syndrome increases the risk of inheriting the mutated gene and developing the condition. If a person has a sibling or close relative with Hunter syndrome, their risk may be higher.
  • Males: Hunter syndrome primarily affects males due to its X-linked inheritance pattern. However, females can still be carriers of the mutated gene and pass it on to their children.

Understanding the causes and risk factors associated with Hunter syndrome can help individuals and their families make informed decisions about managing their health and seeking appropriate medical care when needed.

Symptoms

The most common early symptoms of Hunter syndrome include:

  • Rough or rugged facial features
  • Enlargement of the liver and spleen
  • Airway diseases
  • Stiffness or immobility of joints
  • Behavior problems
  • Cognitive impairment

As the disease progresses or reaches higher severity, other common symptoms may occur. These can include:

  • Seizures or myelopathy (a disorder affecting the spinal cord)
  • Neurodegeneration (gradual loss of function of cells in the brain or spinal cord)
  • Developmental delay
  • Progressive intellectual disability
  • Recurrent ear and respiratory infections
  • Obstructive sleep apnea
  • Enlarged head
  • Abnormal curvature of the spine
  • Thickening of long bones
  • Barrel chest
  • Hearing loss
  • Heart muscle disease
  • Delayed or impaired motor skills
  • Developmental regression (a condition in which a child loses skills or abilities they previously had, such as motor, language, or social skills)

It's important to note that the mild type of Hunter syndrome has a delayed symptom onset and patients usually live into adulthood with minimal neurological dysfunction. On the other hand, the severe form progresses more rapidly and can lead to significant impairments and complications.

Diagnosis

To diagnose Hunter syndrome, healthcare providers commonly perform a series of examinations, tests, and procedures. These may include:

  • Clinical evaluation: A neurologist or healthcare provider will take your medical history and ask about any symptoms you may be experiencing. They will also perform a physical exam to look for any physical signs of the condition.
  • Imaging tests: Tests such as magnetic resonance imaging (MRI), magnetic resonance angiography (MRA), or computed tomography angiography (CTA) may be performed. These tests help to visualize the brain and blood vessels, allowing doctors to identify any atypical bony areas, infarction lesions, or narrowing of the vertebral artery.
  • Digital subtraction angiography (DSA): This test confirms the presence of Hunter Syndrome. It involves injecting a contrast dye into the blood vessels of the head and neck region. The DSA can show normal arteries when the head is in a neutral position, but when the head is rotated, it will reveal stenotic arteries or vascular blockage.

In addition to these common diagnostic procedures, there are additional examinations, tests, and procedures that can help determine the stage or severity of Hunter syndrome. These may include:

  • Motor evoked potential tests: These tests measure the electrical activity in muscles in response to stimulation of the motor cortex of the brain. They can help assess muscle function and detect any abnormalities.
  • Somatosensory evoked potentials: This test measures electrical signals generated by sensory nerves in response to stimulation. It can help evaluate sensory function and identify any abnormalities.
  • Brain stem auditory evoked response: This test measures electrical activity in response to sound stimulation. It can assess hearing function and detect any hearing abnormalities.

It's important to note that these examinations, tests, and procedures are performed by healthcare providers such as neurologists and may vary depending on individual cases. It's always best to consult with a healthcare professional for an accurate diagnosis and appropriate treatment plan for Hunter Syndrome.

Treatment Options

The goals of treatment for Hunter syndrome are to manage symptoms, improve quality of life, and slow down the progression of the disease. There are several approaches to achieve these goals:

  • Enzyme Replacement Therapy (ERT): ERT involves regular infusions of a synthetic version of the enzyme that is deficient in individuals with the condition. This therapy helps replace the missing enzyme and can improve various symptoms, such as respiratory problems and joint stiffness. ERT works by breaking down certain substances in the body that accumulate due to the enzyme deficiency.
  • Hematopoietic Stem Cell Transplantation (HSCT): HSCT involves replacing the patient's bone marrow cells with healthy donor cells that produce the missing enzyme. It can help improve symptoms related to the central nervous system, such as cognitive function and behavior. The goal of HSCT is to provide a long-term source of functional enzyme-producing cells.
  • Symptomatic treatment: Individuals may receive medications to manage pain, respiratory issues, or heart problems associated with the condition.
  • Physical and occupational therapy: These therapies aim to improve mobility, strength, coordination, and independence in daily activities. Physical therapy may include exercises to strengthen muscles and improve joint range of motion, while occupational therapy focuses on enhancing skills needed for daily tasks.
  • Assistive Devices: Assistive devices such as walkers, braces, or wheelchairs may be recommended to support mobility and independence for individuals with Hunter syndrome.
  • Lifestyle Behavior Changes: Making certain lifestyle behavior changes can also contribute to managing Hunter syndrome. These changes may include maintaining a healthy diet, engaging in regular exercise within one's capabilities, practicing good hygiene, and managing weight.

It's important to note that treatment plans for Hunter syndrome are personalized based on individual needs and disease severity. The specific combination of treatments will vary from person to person, depending on factors such as age, symptoms, and overall health.

Progression or Complications

Hunter syndrome is a rare genetic disorder that affects the body's ability to break down certain substances called glycosaminoglycans (GAGs). Without the enzyme needed to break down these substances, GAGs build up in the body's cells and tissues, leading to progressive cellular and multiple organ dysfunction.

The natural progression of Hunter syndrome can vary depending on the severity of the condition. In the severe form of the disease, symptoms typically appear in early childhood, and the disease progresses rapidly. Most patients with severe Hunter syndrome unfortunately die in their twenties.

Symptoms can occur at different ages, with some appearing earlier than others. For example, coarse facial features are seen in about 95% of patients, while cognition impairment is seen in 100% of patients. The median ages of symptom onset range from 2.4 years to 4 years for different symptoms.

The presence and severity of symptoms can also vary depending on the type of Hunter syndrome. The mild type is more likely to have less severe symptoms without cognitive impairment, and patients with this type usually live into adulthood.

Complications commonly associated with Hunter Syndrome include long-term facial weakness, paralysis, or uncontrolled movements. Severe facial paralysis can lead to damage to the cornea (the surface of the eye), resulting in irritation or vision loss. Some patients may also experience long-term pain due to nerve damage.

While there is currently no cure for Hunter syndrome, treatment aims to manage symptoms and improve quality of life. Enzyme replacement therapy (ERT) is a treatment option that involves replacing the missing enzyme with a synthetic version. ERT can help slow down disease progression and reduce some of the complications associated with Hunter syndrome.

Other treatment options may include supportive care to manage specific symptoms such as respiratory problems or joint stiffness. Physical therapy and occupational therapy can also be beneficial in improving mobility and daily functioning.

Treatment plans should be individualized based on each patient's specific needs. It is essential for individuals with Hunter Syndrome to work closely with their healthcare team to determine the most appropriate treatment approach for their specific situation.